UBS maintains Teradata stock rating, awaits ARR growth stabilization

Teradata (TDC) recently reported strong Q2 2025 financial results, with EPS of $0.47 and revenue of $408 million, both surpassing analyst expectations and leading to a positive aftermarket stock reaction. UBS maintained its Neutral rating and $23.00 price target, noting the stock appears undervalued and trades at approximately 7.5 times their calendar year 2026 free cash flow estimate, suggesting limited near-term downside. The firm's analysis indicates a potential bull case for TDC hinges on Total ARR growth stabilizing and significant free cash flow margin expansion, driven by cost controls and operating leverage, despite prevailing cautious investor sentiment.

Analysis

Teradata (TDC) demonstrated strong operational performance in its second quarter of 2025, reporting earnings per share of $0.47 and revenue of $408 million, which surpassed analyst expectations by 17.5% and 1.8% respectively, triggering a positive stock reaction in aftermarket trading. Despite these results, UBS has maintained its Neutral rating and a $23.00 price target. The firm's analysis highlights a valuation that suggests limited near-term downside, with the stock trading at approximately 7.5 times its calendar year 2026 free cash flow estimate. The potential bull case for Teradata is contingent upon the stabilization of Total Annual Recurring Revenue (ARR) growth around breakeven in the near term, before accelerating to low single-digit growth in the following year. UBS models this ARR growth at approximately 1% for fiscal years 2026 and 2027, but anticipates significant free cash flow margin expansion of potentially over 300 basis points in FY26, driven by operating leverage and cost controls. This outlook presents a clear dichotomy between recent strong execution and cautious forward guidance, set against a backdrop of tepid investor sentiment.

Key Decisions for Investors

• Given the valuation at approximately 7.5 times the calendar year 2026 free cash flow estimate, value-oriented investors may find the current price an attractive entry point, as UBS suggests downside appears limited.
• Investors should closely monitor upcoming quarterly reports for stabilization in Total ARR growth, as this is the primary catalyst identified by analysts for unlocking the bull case and realizing projected free cash flow expansion.
• The combination of a strong earnings beat, a 'Neutral' analyst rating, and cautious investor sentiment suggests a 'hold' or gradual accumulation strategy could be prudent, as significant upside appears contingent on the company delivering on its modest growth and margin improvement targets.